Abstract Interleukin (IL)‐1 receptor antagonist (IL‐1Ra), a naturally occurring antagonist of IL‐
1α/IL‐1β signaling pathways, has been attributed to the immunosuppressive effects of …

The role of interleukin 1 receptor antagonist (IL1RA) in mediating the immunosuppressive
effect of mesenchymal stem/stromal cells (MSCs) has been reported in several studies …

Mesenchymal stem cells (MSCs) have been exploited as cellular vectors to treat a wide
array of diseases but the mechanisms responsible for their therapeutic effect remain …

Mesenchymal stem cells (MSCs) can inhibit T cell proliferation; however, the underlying
mechanisms are not clear. In this study, we investigated the mechanisms of the …

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening
inflammatory conditions with no effective pharmacological treatment. Previous studies …

Mesenchymal stem cells (MSCs) are emerging as a promising therapeutic approach of cell-
based therapy for a wide range of autoimmune disorders and degenerative diseases. In …

Mesenchymal stem cells (MSCs) are believed to exert their regenerative effects through
differentiation and modulation of inflammatory responses. However, the relationship …

Mesenchymal stem cells (MSCs) possess a capacity to enhance cutaneous wound healing
that is well characterized. However, the therapeutic effect of MSCs appears to be limited …

Mesenchymal stem cells (MSCs) are suggested to be immune modulators because of their
therapeutic potential in transplantation. In the present study, we evaluated the therapeutic …

This study investigates molecular and cellular mechanisms involved in mesenchymal stem
cell (MSC)‐mediated modulation of IL‐17 signaling during liver fibrosis. Mice received CC l4 …